ATM Function During V(D)J Recombination
ATM Function During V(D)J Recombination
批准号:
10518400
负责人:
BARRY P SLECKMAN
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-02 至 2024-11-30
关键词:
ATM functionAntigen ReceptorsAvidityB-LymphocytesBindingCellsChromatinChromosomal translocationChromosome DeletionCodeComplement Factor BDNADNA DamageDNA Double Strand BreakDNA RepairDefectDouble Strand Break RepairEvolutionG22P1 geneGene CombinationsGenomeGenomic InstabilityGoalsGuide RNAHourHumanIndividualInfectionJ segment geneLIG4 geneLeadLymphocyte antigenMagnetic Resonance ImagingMalignant NeoplasmsMediatingMusNonhomologous DNA End JoiningOncogenicPathway interactionsProteinsReactionReceptor GeneRegulationResolutionRetroviridae InfectionsRoleSignal TransductionT-LymphocyteTestingTissuesV(D)J RecombinationXRCC4 geneXRCC5 geneartemiscancer cellcell typeendonucleasefactor Afactor Cgenome integritylymphoid neoplasmmetaplastic cell transformationnovelpreventprotein functionrepairedresponsescreeningseal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Lymphocyte antigen receptor gene assembly occurs through the V(D)J recombination reaction. This reaction
is initiated when the RAG-1 and RAG-2 proteins, which form the RAG endonuclease, introduces two DNA
double strand breaks (DSBs) at the border of two recombining gene segments and their associated V, D or J
gene segments. This results in the formation of a coding end and a signal end at each DSB. The coding ends
must be joined to form a coding join and the signal ends joined to form a signal join. Also, as a single
individual can make up to 60,000,000 RAG DSBs in an hour in developing B and T cells, pathways must be in
place to prevent un-repaired RAG DSBs from being aberrantly repaired, forming potentially transforming
chromosomal deletions and translocations. The non-homologous end-joining pathway of DNA DSB repair
joins DNA DSBs generated by RAG cleavage. NHEJ relies on four core NHEJ factors, XRCC4, DNA Ligase
IV, Ku70 and Ku80. However, there are other non-core NHEJ factors that function during the NHEJ-mediated
repair of RAG DSBs. For example, coding join formation relies on the ncNHEJ factor, Artemis, which is
endonuclease that opens the hairpin-sealed coding ends generated by RAG cleavage. Artemis is not required
for joining signal ends. In addition, there are other ncNHEJ factors that are not themselves required for RAG
DSB repair, but that likely effect the efficiency of RAG DSB repair or function to prevent aberrant repair of RAG
DSBs that are not joined efficiently. Identifying ncNHEJ factors has been challenging given that their deletion
does not often lead to a demonstrable defect in the repair of RAG DSBs. However, recent studies have
established that combined deficiencies of putative ncNHEJ factors can lead to demonstrable defects in RAG
DSBs repair. This has been a powerful candidate-based approach for identifying several ncNHEJ factors and
elucidating their mechanisms of action in NHEJ-mediated DSB repair and DNA damage responses (DDR).
Indeed, using this type of approach, we have identified a novel ncNHEJ protein, modulator of retroviral
infection (MRI), that binds through its N- and C-terminus to a functionally diverse set of NHEJ and DDR
proteins. We believe that MRI functions as an adaptor during several steps of NHEJ-mediated repair of RAG
DSBs and during the DDR to RAG DSBs. Here we propose a novel unbiased screening approach to identify
the network of ncNHEJ factors that function during RAG DSB repair. We also propose to elucidate the
mechanisms of action of these ncNHEJ factors focusing initially on the novel ncNHEJ factor, MRI, that we
recently discovered that functions in RAG DSB repair. These studies will reveal novel activities required for the
NHEJ-mediated repair of RAG DSBs. These activities will likely be generally relevant to NHEJ in other tissues
and to our understanding to DNA repair defects that lead to genome evolution in cancers.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jaci.2015.03.005
发表时间:
2015-07
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Felgentreff K, Lee YN, Frugoni F, Du L, van der Burg M, Giliani S, Tezcan I, Reisli I, Mejstrikova E, de Villartay JP, Sleckman BP, Manis J, Notarangelo LD]
通讯作者:
Notarangelo LD
DOI:
10.4049/jimmunol.1200829
发表时间:
2012-08-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Yin B, Lee BS, Yang-Iott KS, Sleckman BP, Bassing CH]
通讯作者:
Bassing CH
High-Throughput Screening Approach for Identifying Compounds That Inhibit Nonhomologous End Joining.
DOI:
10.1177/2472555217746324
发表时间:
2018-08
期刊:
SLAS discovery : advancing life sciences R & D
影响因子:
--
作者:
[Bredemeyer AL, Edwards BS, Haynes MK, Morales AJ, Wang Y, Ursu O, Waller A, Sklar LA, Sleckman BP]
通讯作者:
Sleckman BP
DOI:
10.1016/j.cell.2013.05.023
发表时间:
2013-06-06
期刊:
Cell
影响因子:
64.5
作者:
[Callen E, Di Virgilio M, Kruhlak MJ, Nieto-Soler M, Wong N, Chen HT, Faryabi RB, Polato F, Santos M, Starnes LM, Wesemann DR, Lee JE, Tubbs A, Sleckman BP, Daniel JA, Ge K, Alt FW, Fernandez-Capetillo O, Nussenzweig MC, Nussenzweig A]
通讯作者:
Nussenzweig A
DOI:
10.1084/jem.20081326
发表时间:
2009-03-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Helmink BA, Bredemeyer AL, Lee BS, Huang CY, Sharma GG, Walker LM, Bednarski JJ, Lee WL, Pandita TK, Bassing CH, Sleckman BP]
通讯作者:
Sleckman BP
共 18 条
INHIBITORS OF COMPENSATORY NHEJ PATHWAYS
-
批准号:8486208
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2013
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:7879173
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2009
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:8271430
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:8635819
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:8774161
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM Function During V(D)J Recombination
-
批准号:10317289
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM Function During V(D)J Recombination
-
批准号:10307563
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:10062842
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:7742978
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:9180672
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:7578691
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:8386917
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:9275671
-
项目类别:
-
资助金额:$1.66万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
ATM FUNCTION DURING V(D)J RECOMBINATION
-
批准号:7994196
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2008
-
负责人:BARRY P SLECKMAN
-
依托单位:
The V(D)J recombination reaction and its impact on lymphocyte development
-
批准号:9307412
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2000
-
负责人:BARRY P SLECKMAN
-
依托单位:
REGULATION OF TCRB CHAIN GENE REARRANGEMENT
-
批准号:6164006
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2000
-
负责人:BARRY P SLECKMAN
-
依托单位:
Regulation of TCRBeta Chain Gene Rearrangement
-
批准号:7019130
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2000
-
负责人:BARRY P SLECKMAN
-
依托单位:
REGULATION OF TCRB CHAIN GENE REARRANGEMENT
-
批准号:6532822
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2000
-
负责人:BARRY P SLECKMAN
-
依托单位:
REGULATION OF TCRB CHAIN GENE REARRANGEMENT
-
批准号:6374555
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2000
-
负责人:BARRY P SLECKMAN
-
依托单位:
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENT
-
批准号:8460064
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2000
-
负责人:BARRY P SLECKMAN
-
依托单位:
海外基金